Theagene Jean-Manasse 4
4 · MAIA Biotechnology, Inc. · Filed Jul 2, 2024
Insider Transaction Report
Form 4
Theagene Jean-Manasse
Director
Transactions
- Award
Stock Options
2024-06-30+5,728→ 5,728 totalExercise: $3.42From: 2024-06-30Exp: 2034-06-30→ Common Stock (5,728 underlying)
Footnotes (1)
- [F1]The stock options, granted on June 30, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.